Estimator tool
Launch Intelligence
Estimator
Estimate the cost of patient intelligence for your drug launch — by disease area and target market.
01 — Disease areas
Which diseases are you targeting?
02 — Target markets
Which countries are you targeting?
Select all markets relevant to your launch.
Select countries
▼
03 — Launch stage
What stage is your drug launch?
Select the current phase of your programme.
Select stage
▼
Discovery and development
Preclinical research
Clinical research
Regulatory review / submission
Post-market safety monitoring
Other
Your estimate
Estimated investment
€0
.png)
What’s included
Diagnosis journey
Time-to-diagnosis, misdiagnosis rates, and care-seeking triggers across your target cohort.
Referral pathways
How patients move between HCPs, specialists, and institutions before reaching your brand.
Treatment journey
Line of therapy, switching triggers, adherence patterns, and discontinuation reasons.
Daily life impacts
Quality of life, work, relationships, and emotional burden as patients describe it.
Unmet needs
What patients say is missing — from symptoms and side effects to system and support gaps.
This is an estimated investment. We’ll reach out to discuss the details.
Disease areas
Target markets